Derek Maclean
Keine laufenden Positionen mehr
Karriereverlauf von Derek Maclean
Ehemalige bekannte Positionen von Derek Maclean
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
APPLIED MOLECULAR TRANSPORT INC. | Corporate Officer/Principal | 01.09.2018 | 27.12.2023 |
KAI Pharmaceuticals, Inc.
KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
AMGEN INC. | Corporate Officer/Principal | - | - |
RELYPSA INC | Corporate Officer/Principal | - | - |
Ausbildung von Derek Maclean
The University of Edinburgh | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Vereinigtes Königreich | 2 |
Operativ
Corporate Officer/Principal | 4 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
APPLIED MOLECULAR TRANSPORT INC. | Health Technology |
AMGEN INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Relypsa, Inc.
Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Relypsa, Inc. operates as a bio-pharmaceutical company, which engages in the development and commercialization of late-stage medicines in the iron deficiency, nephrology, and cardio-renal therapeutic areas. It offers Veltassa, a potassium binder approved for the treatment of hyperkalemia. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA. | Health Technology |
KAI Pharmaceuticals, Inc.
KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Derek Maclean
- Erfahrung